Clinical Trial Update: Loncastuximab Tesirine in Combination With DA-EPOCH-R in Patients With Previously Untreated Aggressive B-cell Lymphoid Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial update examining loncastuximab tesirine with DA-EPOCH-R for previously untreated aggressive B-cell lymphoid malignancies; the study is currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Burkitt Lymphoma

Drugs mentioned

• DA-EPOCH-R
• Loncastuximab tesirine (loncastuximab tesirine)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: B-cell Lymphoma, Burkitt Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING